Product Name | Roscovitine |
Description |
p34/cdc2 inhibitor |
Purity | >99% (TLC and HPLC); NMR (Conforms) |
CAS No. | 186692-46-6 |
Molecular Formula | C19H26N6O |
Molecular Weight | 354.4 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | May be dissolved in ethanol (10mg/mL); or DMSO (10mg/mL, warm) |
Source | Synthetic |
Appearance | White to off-white solid |
SMILES | [C@H](NC2=NC1=C(N=C[N]1C(C)C)C(=N2)NCC3=CC=CC=C3)(CO)CC |
InChI | InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 |
InChIKey | BTIHMVBBUGXLCJ-OAHLLOKOSA-N |
Safety Phrases |
Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
Cite This Product | Roscovitine (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-472) |
Alternative Names | 2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol, 6-Benzylamino-2-(R)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine, 2(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine |
Research Areas | Cell Signaling |
PubChem ID | 160355 |
Scientific Background | Roscovitine is a potent and selective inhibitor of cyclin-dependent kinases (CDKs). It is specifically selective for CDK1/cyclin B kinase, CDK2 and CDK5/p35. It inhibits M phase promoting factor kinase activity and affects calcium channel gating. |
References | 1. De Azevedo, et al. (1997) Eur. J. Biochem. 243(1-2): 518–526. |
Reviews
There are no reviews yet.